相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Exploring chitosan-shelled nanobubbles to improve HER2+immunotherapy via dendritic cell targeting
Monica Argenziano et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2022)
Mechanical thrombectomy versus intravenous thrombolysis for distal large-vessel occlusion: a systematic review and meta-analysis of observational studies
Muhammad Waqas et al.
NEUROSURGICAL FOCUS (2021)
Hyperfunctional complement C3 promotes C5-dependent atypical hemolytic uremic syndrome in mice
Kate Smith-Jackson et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis
Federico Colombo et al.
JOURNAL OF AUTOIMMUNITY (2019)
Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome
Paola Adele Lonati et al.
FRONTIERS IN IMMUNOLOGY (2019)
New insight into antiphospholipid syndrome: antibodies to β2glycoprotein I-domain 5 fail to induce thrombi in rats
Paolo Durigutto et al.
HAEMATOLOGICA (2019)
Obstetric and vascular antiphospholipid syndrome: same antibodies but different diseases?
Pier Luigi Meroni et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Folate-conjugated nanobubbles selectively target and kill cancer cells via ultrasound-triggered intracellular explosion
Shuxin Shen et al.
BIOMATERIALS (2018)
Diagnosis and Management of the Antiphospholipid Syndrome
Karl J. Lackner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The role of plasminogen activators in stroke treatment: fibrinolysis and beyond
Audrey M. Thiebaut et al.
LANCET NEUROLOGY (2018)
Thrombolysis and Thrombectomy for Acute Ischemic Stroke: Strengths and Synergies
Bruce C. V. Campbell
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2017)
Combining doxorubicin-nanobubbles and shockwaves for anaplastic thyroid cancer treatment: preclinical study in a xenograft mouse model
Francesca Marano et al.
ENDOCRINE-RELATED CANCER (2017)
Complement activation in antiphospholipid syndrome and its inhibition to prevent rethrombosis after arterial surgery
Pier Luigi Meroni et al.
BLOOD (2016)
A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles
Sara Capolla et al.
NANO RESEARCH (2016)
Thrombus-Targeted Theranostic Microbubbles: A New Technology towards Concurrent Rapid Ultrasound Diagnosis and Bleeding-free Fibrinolytic Treatment of Thrombosis
Xiaowei Wang et al.
THERANOSTICS (2016)
Ferric Chloride-induced Murine Thrombosis Models
Wei Li et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2016)
Nanobubbles: a promising efficient tool for therapeutic delivery
Roberta Cavalli et al.
THERAPEUTIC DELIVERY (2016)
Preparation and in vitro characterization of chitosan nanobubbles as theranostic agents
R. Cavalli et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2015)
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients
R. Cervera et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice
P. Macor et al.
LEUKEMIA (2015)
The global anti-phospholipid syndrome score in primary APS
Savino Sciascia et al.
RHEUMATOLOGY (2015)
A non-complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome
Chiara Agostinis et al.
BLOOD (2014)
Towards Effective and Safe Thrombolysis and Thromboprophylaxis
Xiaowei Wang et al.
CIRCULATION RESEARCH (2014)
In vivo thrombolysis with targeted microbubbles loading tissue plasminogen activator in a rabbit femoral artery thrombus model
Xing Hua et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2014)
Micro- and nanobubbles: A versatile non-viral platform for gene delivery
Roberta Cavalli et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
The Pathogenesis of the Antiphospholipid Syndrome
Bill Giannakopoulos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine- Loaded Anti-CD20 Nanoparticles
Nelly Mezzaroba et al.
PLOS ONE (2013)
The significance of autoantibodies against β2-glycoprotein I
Philip G. de Groot et al.
BLOOD (2012)
New chitosan nanobubbles for ultrasound-mediated gene delivery: preparation and in vitro characterization
Roberta Cavalli et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)
Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy
Jason R. McCarthy et al.
NANOMEDICINE (2012)
In vivo distribution of β2 glycoprotein I under various pathophysiologic conditions
Chiara Agostinis et al.
BLOOD (2011)
A fibrin-specific thrombolytic nanomedicine approach to acute ischemic stroke
Jon N. Marsh et al.
NANOMEDICINE (2011)
Pathogenesis of antiphospholipid syndrome: understanding the antibodies
Pier Luigi Meroni et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
The fabrication of novel nanobubble ultrasound contrast agent for potential tumor imaging
Zhanwen Xing et al.
NANOTECHNOLOGY (2010)
Multimodal Nanoagents for the Detection of Intravascular Thrombi
Jason R. McCarthy et al.
BIOCONJUGATE CHEMISTRY (2009)
The role of monocytes in thrombotic disorders Insights from tissue factor, monocyte-platelet aggregates and novel mechanisms
Eduard Shantsila et al.
THROMBOSIS AND HAEMOSTASIS (2009)
In vivo clot lysis of human thrombus with intravenous abciximab immunobubbles and ultrasound
Angelika Alonso et al.
THROMBOSIS RESEARCH (2009)
The use of the Chandler loop to examine the interaction potential of NXY-059 on the thrombolytic properties of rtPA on human thrombi in vitro
N. J. Mutch et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Conformation-specific blockade of the integrin GPIIb/IIIa - A novel antiplatelet strategy that selectively targets activated platelets
Meike Schwarz et al.
CIRCULATION RESEARCH (2006)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Thrombus formation induced by antibodies to β2-glycoprotein I is complement dependent and requires a priming factor
F Fischetti et al.
BLOOD (2005)
Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanism
M Colucci et al.
BLOOD (2004)
Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo
A Dobrina et al.
BLOOD (2002)
分享论文
